- Home
- SYTA vs ENVB Comparison
SYTA vs ENVB Comparison
Compare SYTA & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- ENVB
- Stock Information
- Founded
- SYTA N/A
- ENVB 1994
- Country
- SYTA Canada
- ENVB United States
- Employees
- SYTA N/A
- ENVB N/A
- Industry
- SYTA Telecommunications Equipment
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- ENVB Health Care
- Exchange
- SYTA Nasdaq
- ENVB Nasdaq
- Market Cap
- SYTA 3.1M
- ENVB 3.2M
- IPO Year
- SYTA 2020
- ENVB N/A
- Fundamental
- Price
- SYTA $2.31
- ENVB $1.30
- Analyst Decision
- SYTA
- ENVB Strong Buy
- Analyst Count
- SYTA 0
- ENVB 1
- Target Price
- SYTA N/A
- ENVB $10.00
- AVG Volume (30 Days)
- SYTA 9.5M
- ENVB 55.8K
- Earning Date
- SYTA 05-27-2025
- ENVB 05-14-2025
- Dividend Yield
- SYTA N/A
- ENVB N/A
- EPS Growth
- SYTA N/A
- ENVB N/A
- EPS
- SYTA N/A
- ENVB N/A
- Revenue
- SYTA $11,740,024.00
- ENVB N/A
- Revenue This Year
- SYTA $14.02
- ENVB N/A
- Revenue Next Year
- SYTA N/A
- ENVB N/A
- P/E Ratio
- SYTA N/A
- ENVB N/A
- Revenue Growth
- SYTA 41.25
- ENVB N/A
- 52 Week Low
- SYTA $1.00
- ENVB $1.01
- 52 Week High
- SYTA $885.60
- ENVB $222.75
- Technical
- Relative Strength Index (RSI)
- SYTA 66.79
- ENVB 37.06
- Support Level
- SYTA $1.10
- ENVB $1.20
- Resistance Level
- SYTA $2.00
- ENVB $1.49
- Average True Range (ATR)
- SYTA 0.30
- ENVB 0.10
- MACD
- SYTA 0.13
- ENVB 0.10
- Stochastic Oscillator
- SYTA 60.79
- ENVB 34.84
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.